Department of Cardiology, Tokyo Metropolitan Tama Medical Center, 2-8-29 Musashidai, Fuchu, 183-8524 Tokyo, Japan.
Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan.
Eur Heart J Acute Cardiovasc Care. 2023 Dec 21;12(12):834-846. doi: 10.1093/ehjacc/zuad110.
Arrhythmia is a major complication of Takotsubo syndrome (TTS). However, its incidence, management, and prognostic impact remain to be elucidated in a large cohort.
We retrospectively identified 16 713 patients hospitalized for TTS between July 2010 and March 2021 from the Japanese Diagnosis Procedure Combination database. Serious arrhythmias were defined as ventricular tachycardia/fibrillation (VT/VF), 2nd-/3rd-degree atrioventricular block (AVB), sick sinus syndrome (SSS), or unspecified arrhythmias requiring device treatment. Patient characteristics and outcomes were compared based on the occurrence of serious arrhythmias. The overall incidence proportion of serious arrhythmias was 6.2% (n = 1036; 449 VT/VF, 283 2nd-/3rd-degree AVB, 133 SSS, 55 multiple arrhythmias, 116 others), which remained stable over 11 years. The arrhythmia group was younger, more often male, and exhibited greater impairment in activities of daily living (ADLs) and consciousness than the non-arrhythmia group. Although crude in-hospital mortality was higher in the arrhythmia group (9.6% vs. 5.0%, P < 0.001), the significant association between arrhythmias and mortality disappeared after adjustment for confounders (odds ratio = 1.15, 95% confidence interval = 0.90-1.49). Meanwhile, age, sex, ADLs, consciousness level, and Charlson comorbidity index were significantly associated with mortality. In the arrhythmia group, 254 (24.5%) patients received pacemakers (18.4%) or defibrillators (6.1%), which were implanted at a median of 8 and 19 days after admission, respectively.
Arrhythmias are not uncommon in TTS. Patients' background characteristics, rather than arrhythmia itself, may be associated with in-hospital mortality. Given the reversibility of cardiac dysfunction in TTS, there may be unnecessary device implantations for arrhythmias occurring as sequelae to TTS, warranting further investigations.
心律失常是心尖球形综合征(TTS)的主要并发症。然而,在大型队列中,其发生率、处理方法和预后影响仍有待阐明。
我们从日本诊断程序组合数据库中回顾性地确定了 2010 年 7 月至 2021 年 3 月期间因 TTS 住院的 16713 例患者。严重心律失常定义为室性心动过速/颤动(VT/VF)、2 度/3 度房室传导阻滞(AVB)、病态窦房结综合征(SSS)或需要器械治疗的未特指心律失常。根据严重心律失常的发生情况比较患者特征和结局。严重心律失常的总体发生率为 6.2%(n=1036;449 例 VT/VF、283 例 2 度/3 度 AVB、133 例 SSS、55 例多种心律失常、116 例其他),在 11 年内保持稳定。心律失常组比非心律失常组更年轻,更常为男性,日常生活活动(ADL)和意识受损更严重。虽然心律失常组的住院死亡率较高(9.6% vs. 5.0%,P<0.001),但在校正混杂因素后,心律失常与死亡率之间的显著相关性消失(优势比=1.15,95%置信区间=0.90-1.49)。同时,年龄、性别、ADL、意识水平和 Charlson 合并症指数与死亡率显著相关。在心律失常组中,254 例(24.5%)患者接受了起搏器(18.4%)或除颤器(6.1%)治疗,分别在入院后 8 天和 19 天中位数时植入。
心律失常在 TTS 中并不少见。患者的背景特征,而不是心律失常本身,可能与住院死亡率相关。鉴于 TTS 中心脏功能障碍的可逆性,TTS 后发生的心律失常可能需要不必要的器械植入,这需要进一步研究。